Wondering if any of our science/medical oriented m
Post# of 148159
That link takes you to the home page and there are some impressive press releases on the left side.
They submitted a BLA for children's GVHD on April 1. They now have the same product undergoing a Phase 3 trial for COVID (targeting severe patients with ARDS). And, they released strong "anectodal" data on the use of the product on an EIND basis.
They are on Nasdaq and their stock jumped from about $6 to $15 on Friday. I think their current market cap is about the same as CYDY.
There was light discussion on them on Friday, but I didn't see anyone weigh in on their method-of-action.
If nothing else, they write a very clear press release!